The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Left Atrial Appendage (LAA) Closure-Global Market Insights and Sales Trends 2024
Synopsis
Left atrial appendage closure (LAAC) is a treatment strategy to reduce the risk of left atrial appendage blood clots from entering the bloodstream and causing a stroke in patients with non-valvular atrial fibrillation (AF).
The global Left Atrial Appendage (LAA) Closure market size is expected to reach US$ 709 million by 2029, growing at a CAGR of 15.8% from 2023 to 2029. The market is mainly driven by the significant applications of Left Atrial Appendage (LAA) Closure in various end use industries. The expanding demands from the Hospitals, ASCs and Specialty Clinic,, are propelling Left Atrial Appendage (LAA) Closure market. Epicardial LAA Closure Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Endocardial LAA Closure Device segment is estimated at % CAGR for the next seven-year period.
On March 13, 2015, the U.S. Food and Drug Administration approved the WATCHMAN™ LAAC Implant, from Boston Scientific, to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular AF who are at increased risk of stroke and are recommended for blood thinning medicines, are suitable for warfarin and have an appropriate reason to seek a non-drug alternative to warfarin. The Watchman implant was studied in two randomized clinical trials and several clinical registries. The implant was approved in Europe in 2009.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Left Atrial Appendage (LAA) Closure, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Left Atrial Appendage (LAA) Closure market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Left Atrial Appendage (LAA) Closure market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Left Atrial Appendage (LAA) Closure sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Left Atrial Appendage (LAA) Closure covered in this report include AtriCure, Boston Scientific, Coherex Medical, Abbott, Occlutech, Lifetech Scientific and SentreHEART, etc.
The global Left Atrial Appendage (LAA) Closure market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AtriCure
Boston Scientific
Coherex Medical
Abbott
Occlutech
Lifetech Scientific
SentreHEART
Global Left Atrial Appendage (LAA) Closure market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Left Atrial Appendage (LAA) Closure market, Segment by Type:
Epicardial LAA Closure Device
Endocardial LAA Closure Device
Global Left Atrial Appendage (LAA) Closure market, by Application
Hospitals
ASCs
Specialty Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Left Atrial Appendage (LAA) Closure companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Left atrial appendage closure (LAAC) is a treatment strategy to reduce the risk of left atrial appendage blood clots from entering the bloodstream and causing a stroke in patients with non-valvular atrial fibrillation (AF).
The global Left Atrial Appendage (LAA) Closure market size is expected to reach US$ 709 million by 2029, growing at a CAGR of 15.8% from 2023 to 2029. The market is mainly driven by the significant applications of Left Atrial Appendage (LAA) Closure in various end use industries. The expanding demands from the Hospitals, ASCs and Specialty Clinic,, are propelling Left Atrial Appendage (LAA) Closure market. Epicardial LAA Closure Device, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Endocardial LAA Closure Device segment is estimated at % CAGR for the next seven-year period.
On March 13, 2015, the U.S. Food and Drug Administration approved the WATCHMAN™ LAAC Implant, from Boston Scientific, to reduce the risk of thromboembolism from the left atrial appendage in patients with non-valvular AF who are at increased risk of stroke and are recommended for blood thinning medicines, are suitable for warfarin and have an appropriate reason to seek a non-drug alternative to warfarin. The Watchman implant was studied in two randomized clinical trials and several clinical registries. The implant was approved in Europe in 2009.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Left Atrial Appendage (LAA) Closure, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Left Atrial Appendage (LAA) Closure market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Left Atrial Appendage (LAA) Closure market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Left Atrial Appendage (LAA) Closure sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Left Atrial Appendage (LAA) Closure covered in this report include AtriCure, Boston Scientific, Coherex Medical, Abbott, Occlutech, Lifetech Scientific and SentreHEART, etc.
The global Left Atrial Appendage (LAA) Closure market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AtriCure
Boston Scientific
Coherex Medical
Abbott
Occlutech
Lifetech Scientific
SentreHEART
Global Left Atrial Appendage (LAA) Closure market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Left Atrial Appendage (LAA) Closure market, Segment by Type:
Epicardial LAA Closure Device
Endocardial LAA Closure Device
Global Left Atrial Appendage (LAA) Closure market, by Application
Hospitals
ASCs
Specialty Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Left Atrial Appendage (LAA) Closure companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Left Atrial Appendage (LAA) Closure
1.1 Left Atrial Appendage (LAA) Closure Market Overview
1.1.1 Left Atrial Appendage (LAA) Closure Product Scope
1.1.2 Left Atrial Appendage (LAA) Closure Market Status and Outlook
1.2 Global Left Atrial Appendage (LAA) Closure Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Left Atrial Appendage (LAA) Closure Market Size by Region (2018-2029)
1.4 Global Left Atrial Appendage (LAA) Closure Historic Market Size by Region (2018-2023)
1.5 Global Left Atrial Appendage (LAA) Closure Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Left Atrial Appendage (LAA) Closure Market Size (2018-2029)
1.6.1 North America Left Atrial Appendage (LAA) Closure Market Size (2018-2029)
1.6.2 Europe Left Atrial Appendage (LAA) Closure Market Size (2018-2029)
1.6.3 Asia-Pacific Left Atrial Appendage (LAA) Closure Market Size (2018-2029)
1.6.4 Latin America Left Atrial Appendage (LAA) Closure Market Size (2018-2029)
1.6.5 Middle East & Africa Left Atrial Appendage (LAA) Closure Market Size (2018-2029)
2 Left Atrial Appendage (LAA) Closure Market by Type
2.1 Introduction
2.1.1 Epicardial LAA Closure Device
2.1.2 Endocardial LAA Closure Device
2.2 Global Left Atrial Appendage (LAA) Closure Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Left Atrial Appendage (LAA) Closure Historic Market Size by Type (2018-2023)
2.2.2 Global Left Atrial Appendage (LAA) Closure Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Left Atrial Appendage (LAA) Closure Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Left Atrial Appendage (LAA) Closure Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Left Atrial Appendage (LAA) Closure Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Left Atrial Appendage (LAA) Closure Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Left Atrial Appendage (LAA) Closure Revenue Breakdown by Type (2018-2029)
3 Left Atrial Appendage (LAA) Closure Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 ASCs
3.1.3 Specialty Clinic
3.2 Global Left Atrial Appendage (LAA) Closure Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Left Atrial Appendage (LAA) Closure Historic Market Size by Application (2018-2023)
3.2.2 Global Left Atrial Appendage (LAA) Closure Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Left Atrial Appendage (LAA) Closure Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Left Atrial Appendage (LAA) Closure Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Left Atrial Appendage (LAA) Closure Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Left Atrial Appendage (LAA) Closure Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Left Atrial Appendage (LAA) Closure Revenue Breakdown by Application (2018-2029)
4 Left Atrial Appendage (LAA) Closure Competition Analysis by Players
4.1 Global Left Atrial Appendage (LAA) Closure Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Left Atrial Appendage (LAA) Closure as of 2022)
4.3 Date of Key Players Enter into Left Atrial Appendage (LAA) Closure Market
4.4 Global Top Players Left Atrial Appendage (LAA) Closure Headquarters and Area Served
4.5 Key Players Left Atrial Appendage (LAA) Closure Product Solution and Service
4.6 Competitive Status
4.6.1 Left Atrial Appendage (LAA) Closure Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AtriCure
5.1.1 AtriCure Profile
5.1.2 AtriCure Main Business
5.1.3 AtriCure Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.1.4 AtriCure Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.1.5 AtriCure Recent Developments
5.2 Boston Scientific
5.2.1 Boston Scientific Profile
5.2.2 Boston Scientific Main Business
5.2.3 Boston Scientific Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.2.4 Boston Scientific Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.2.5 Boston Scientific Recent Developments
5.3 Coherex Medical
5.3.1 Coherex Medical Profile
5.3.2 Coherex Medical Main Business
5.3.3 Coherex Medical Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.3.4 Coherex Medical Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Recent Developments
5.4 Abbott
5.4.1 Abbott Profile
5.4.2 Abbott Main Business
5.4.3 Abbott Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.4.4 Abbott Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Recent Developments
5.5 Occlutech
5.5.1 Occlutech Profile
5.5.2 Occlutech Main Business
5.5.3 Occlutech Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.5.4 Occlutech Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.5.5 Occlutech Recent Developments
5.6 Lifetech Scientific
5.6.1 Lifetech Scientific Profile
5.6.2 Lifetech Scientific Main Business
5.6.3 Lifetech Scientific Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.6.4 Lifetech Scientific Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.6.5 Lifetech Scientific Recent Developments
5.7 SentreHEART
5.7.1 SentreHEART Profile
5.7.2 SentreHEART Main Business
5.7.3 SentreHEART Left Atrial Appendage (LAA) Closure Products, Services and Solutions
5.7.4 SentreHEART Left Atrial Appendage (LAA) Closure Revenue (US$ Million) & (2018-2023)
5.7.5 SentreHEART Recent Developments
6 North America
6.1 North America Left Atrial Appendage (LAA) Closure Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Left Atrial Appendage (LAA) Closure Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Left Atrial Appendage (LAA) Closure Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Left Atrial Appendage (LAA) Closure Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Left Atrial Appendage (LAA) Closure Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Left Atrial Appendage (LAA) Closure Market Dynamics
11.1 Left Atrial Appendage (LAA) Closure Industry Trends
11.2 Left Atrial Appendage (LAA) Closure Market Drivers
11.3 Left Atrial Appendage (LAA) Closure Market Challenges
11.4 Left Atrial Appendage (LAA) Closure Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
